Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of inactivated whole-virus H7N9 influenza vaccine in healthy subjects
CTR20170834Phase 2Active
- Sponsor
- Hualan Biological Vaccine
- Start
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of h7n9 inactivated whole-virus influenza vaccine in avian influenza A H7N9 (A(H7N9)), sponsored by Hualan Biological Vaccine. Started Aug 2017; status: active.
02
Drugs
h7n9 inactivated whole-virus influenza vaccine
03
Conditions
avian influenza A H7N9 (A(H7N9))
Beyond the preview
Go deeper on CTR20170834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170834.